Biora Therapeutics (NYSE: BIOR) — Perfil da empresa, notícias e dados financeiros
Biora Therapeutics develops innovative drug delivery technologies, targeting neurodegenerative diseases to improve patient outcomes.
Biora Therapeutics
Biora Therapeutics (NASDAQ:BIOR) focuses on pioneering healthcare solutions by developing innovative technologies for drug delivery and diagnostics, targeting diseases with significant unmet medical needs. Their projects are designed around enhancing patient outcomes through precision therapeutics and advanced diagnostic tools, striving to bridge the gap between current treatment modalities and the evolving healthcare demands. Biora aims to redefine medical treatments by ensuring more accessible, efficient, and personalized healthcare interventions, aligning with their objective to radically improve patient quality of life while addressing the complexities of modern diseases.
Resumo
Operações
Produtos e/ou serviços de Biora Therapeutics
- SmartPill, a non-invasive, ingestible capsule designed for diagnostic evaluation of GI disorders.
- RaniPill, a robotic pill for oral delivery of biologics, potentially replacing injections.
- BioTherapeutics, focused on creating ingestible therapeutics for chronic diseases management.
equipe executiva do Biora Therapeutics
- Mr. Aditya P. Mohanty M.B.A.CEO & Director
- Mr. Clarke Neumann J.D.Senior VP, General Counsel & Secretary
- Mr. Kevin Howe Ph.D.Senior VP of Strategic Operations
- Dr. Paul Shabram M.B.A.Head of Technical Operations
- Mr. James Knight M.B.A.Head of Business Development
Principais indicadores financeiros
Resultados divulgados pela Biora Therapeutics, em USD.
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 4 mil | -67,1 mi | -124,1 mi | |
| 305 mil | -61,8 mi | -38,2 mi | |
| 1,2 mi | -117,8 mi | -178,5 mi | |
| 74,3 mi | -195,2 mi | -192,5 mi |